Early detection test for ovarian cancer closer with funding boost

home
Published
Research into the development of an early detection test for ovarian cancer at Griffith University’s Institute for Glycomics has been given a $300,000 funding boost from The Bourne Foundation and a further significant funding pledge from Tour de Cure. “Despite decades of research, there is currently no easily accessible, non-invasive and reliable early detection test […]

Institute for Glycomics and Sienna Diagnostics to develop novel cancer diagnostic

Institute for Glycomics
Published
Researchers from the Institute for Glycomics and the University of Adelaide, have entered into an exclusive licensing deal with Sienna Cancer Diagnostics Ltd to commercialise a novel cancer diagnostic tool. Together, the teams of researchers have engineered a unique protein, called SubB2M, that binds specifically to a sugar molecule only present in cancer cells – a potential […]

Institute for Glycomics researchers tackle COVID-19

COVID-19
Published
Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines and drugs to prevent or cure COVID-19. The teams are led by the Institute’s group leaders Professor Mark von Itzstein AO, Professor Michael Good AO, Professor Michael Jennings, and Professor Johnson Mak, all world-renowned research […]